Gerald Illerhaus
Klinikum Stuttgart · Klinikum der Landeshauptstadt Stuttgart gKAö · Klinik für Hämatologie, Onkologie und PalliativmedizinStuttgart Cancer
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gerald Illerhaus as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:59 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04931368 · OptiMATe: De-escalated Induction Treatment in Primary CNS LymphomaKlinikum Stuttgart · active not recruiting · Primary Central Nervous System Lymphoma · principal investigator
- Ph1NCT04073147 · Venetoclax and Obinutuzumab for Relapsed/Refractory Primary CNS LymphomaKlinikum Stuttgart · terminated · Primary CNS Lymphoma · study chair
- Ph2NCT02669511 · PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System LymphomaPIQUR Therapeutics AG · completed · Primary Central Nervous System Lymphoma · principal investigator
- Ph3NCT02531841 · High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS LymphomaUniversity Hospital Freiburg · unknown · Diffuse Large B-cell-lymphoma · principal investigator
- Ph2NCT01011920 · Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) LymphomaInternational Extranodal Lymphoma Study Group (IELSG) · completed · Central Nervous System Lymphoma · study chair
- Ph2NCT00989352 · Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-LymphomaUniversity Hospital Freiburg · unknown · Primary Non Hodgkin Lymphoma of the Central Nervous System · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:59 UTC. The ranking covers the 200 most relevant of 28 PubMed records, and a shared surname and initials can bring in a namesake. All 28 on PubMed
- 2,188 citationsRCR 101.7
- 601 citationsRCR 22.0
- 507 citationsRCR 19.1
- 393 citationsRCR 15.9
- 318 citationsRCR 11.8
- Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer.N Engl J Med · 2025261 citationsRCR 71.1
- High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.J Clin Oncol · 2006215 citationsRCR 5.7
- 162 citationsRCR 14.8
- High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).Leukemia · 2017133 citationsRCR 5.1
- High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.Lancet Haematol · 2016130 citationsRCR 5.5